Nonetheless, the results shown above can provide guidance to clinicians so that they are not misled by tumor size, since CDKN2A-mutated tumors with associated poor survival prognosis are often smaller than CDKN2A-intact tumors8,14. Here, CDKN2A is linked to neoplasm.